PURPOSE: The purpose of the study was to evaluate the neurodevelopmental outcome in infants with congenital diaphragmatic hernia (CDH). METHODS: Between June 2004 and September 2007, 41 CDH survivors were prospectively enrolled in an interdisciplinary follow-up program. Neurodevelopmental status was evaluated using the Bayley Scales of Infant Development II (prior 2006, n = 9), the Bayley Scales of Infant Development III (after 2006, n = 27), or the Wechsler Preschool and Primary Scale of Intelligence III (children older than 4 years, n = 5). Scores were grouped as average, mildly delayed, and severely delayed by standard deviation intervals (115-85, 71-84, <70), and mixed if average and mildly delayed in either cognitive or language. RESULTS: Median age at last assessment was 24 months (range, 6-62). Average, mixed, mildly delayed, and severely delayed scores for neurocognitive and language skills were found in 49%, 19%, 17%, and 15%, respectively. Psychomotor scores were normal, mildly delayed, and severely delayed in 46%, 23%, and 31%, respectively. Autism was present in 7%. Abnormal muscle tonicity was found in 51% (49% hypotonic, 2% hypertonic). Multivariate risk factors for borderline or delayed neurodevelopmental, neurocognitive, and/or psychomotor outcome were intrathoracic liver position (P = .02), presence of a right-sided CDH (P = .02), extracorporeal membrane oxygenation need (P < .001), Gore-Tex patch repair (P = .02), O(2) requirement at 30 days of life (P < .01), and hypotonicity (P < .01). CONCLUSIONS: The prospective evaluation in an interdisciplinary follow-up program uncovered striking morbidities in neurodevelopmental status in approximately half of the CDH infants. The most common neurologic sequelae are neuromuscular hypotonicity and psychomotor dysfunction. Patient-specific factors are important determinants of adverse neurologic outcome.
PURPOSE: The purpose of the study was to evaluate the neurodevelopmental outcome in infants with congenital diaphragmatic hernia (CDH). METHODS: Between June 2004 and September 2007, 41 CDH survivors were prospectively enrolled in an interdisciplinary follow-up program. Neurodevelopmental status was evaluated using the Bayley Scales of Infant Development II (prior 2006, n = 9), the Bayley Scales of Infant Development III (after 2006, n = 27), or the Wechsler Preschool and Primary Scale of Intelligence III (children older than 4 years, n = 5). Scores were grouped as average, mildly delayed, and severely delayed by standard deviation intervals (115-85, 71-84, <70), and mixed if average and mildly delayed in either cognitive or language. RESULTS: Median age at last assessment was 24 months (range, 6-62). Average, mixed, mildly delayed, and severely delayed scores for neurocognitive and language skills were found in 49%, 19%, 17%, and 15%, respectively. Psychomotor scores were normal, mildly delayed, and severely delayed in 46%, 23%, and 31%, respectively. Autism was present in 7%. Abnormal muscle tonicity was found in 51% (49% hypotonic, 2% hypertonic). Multivariate risk factors for borderline or delayed neurodevelopmental, neurocognitive, and/or psychomotor outcome were intrathoracic liver position (P = .02), presence of a right-sided CDH (P = .02), extracorporeal membrane oxygenation need (P < .001), Gore-Tex patch repair (P = .02), O(2) requirement at 30 days of life (P < .01), and hypotonicity (P < .01). CONCLUSIONS: The prospective evaluation in an interdisciplinary follow-up program uncovered striking morbidities in neurodevelopmental status in approximately half of the CDH infants. The most common neurologic sequelae are neuromuscular hypotonicity and psychomotor dysfunction. Patient-specific factors are important determinants of adverse neurologic outcome.
Authors: Christopher A Guidry; Tjasa Hranjec; Bradley M Rodgers; Bartholomew Kane; Eugene D McGahren Journal: J Am Coll Surg Date: 2012-02-28 Impact factor: 6.113
Authors: Pramod Puligandla; Erik Skarsgard; Martin Offringa; Ian Adatia; Robert Baird; Michelle Bailey; Mary Brindle; Priscilla Chiu; Arthur Cogswell; Shyamala Dakshinamurti; Hélène Flageole; Richard Keijzer; Douglas McMillan; Titilayo Oluyomi-Obi; Thomas Pennaforte; Thérèse Perreault; Bruno Piedboeuf; S. Patricia Riley; Greg Ryan; Anne Synnes; Michael Traynor Journal: CMAJ Date: 2018-01-29 Impact factor: 8.262
Authors: R Radhakrishnan; S Merhar; J Meinzen-Derr; B Haberman; F Y Lim; P Burns; E Zorn; B Kline-Fath Journal: AJNR Am J Neuroradiol Date: 2016-05-05 Impact factor: 3.825
Authors: Claudia Henzler; Frank G Zöllner; Meike Weis; Fabian Zimmer; Stefan O Schoenberg; Katrin Zahn; Thomas Schaible; K Wolfgang Neff Journal: In Vivo Date: 2017 Jul-Aug Impact factor: 2.155
Authors: R Radhakrishnan; S L Merhar; W Su; B Zhang; P Burns; F Y Lim; B M Kline-Fath Journal: AJNR Am J Neuroradiol Date: 2017-12-21 Impact factor: 3.825
Authors: Julia Wynn; Gudrun Aspelund; Annette Zygmunt; Charles J H Stolar; George Mychaliska; Jennifer Butcher; Foong-Yen Lim; Teresa Gratton; Douglas Potoka; Kate Brennan; Ken Azarow; Barbara Jackson; Howard Needelman; Timothy Crombleholme; Yuan Zhang; Jimmy Duong; Marc S Arkovitz; Wendy K Chung; Christiana Farkouh Journal: J Pediatr Surg Date: 2013-10 Impact factor: 2.545
Authors: Jennifer R Benjamin; Kathryn E Gustafson; P Brian Smith; Kirsten M Ellingsen; K Brooke Tompkins; Ronald N Goldberg; C Michael Cotten; Ricki F Goldstein Journal: J Pediatr Surg Date: 2013-04 Impact factor: 2.545
Authors: Enrico Danzer; Casey Hoffman; Jo Ann D'Agostino; Judith S Miller; Lindsay N Waqar; Marsha Gerdes; Judy C Bernbaum; Hannah Rosenthal; Natalie E Rintoul; Lisa M Herkert; William H Peranteau; Alan W Flake; N Scott Adzick; Holly L Hedrick Journal: J Autism Dev Disord Date: 2018-06